πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

2,562 results for β€œCancer” Clear

  1. Fostamatinib 100 mg bid and Paclitaxel

    RIGEL PHARMACEUTICALS INC

    Ovarian Cancer

    phase 1 small molecule completed

    1 trial

  2. Furmonertinib

    ArriVent BioPharma

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  3. GB-4362

    Generate Biomedicines

    Advanced Urothelial Cancer

    phase 1 small molecule active

    1 trial

  4. GB-5267 - IV only

    Generate Biomedicines

    Platinum-resistant Ovarian Cancer

    phase 1 mab active

    1 trial

  5. GZ17-6.02

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  6. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 mab active

    1 trial

  7. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  8. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  9. HER-2/neu peptide vaccine

    Marker Therapeutics

    HER2-positive Breast Cancer

    phase 1 mab completed

    1 trial

  10. HER3-DXd

    Daiichi Sankyo

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  11. HWK-007

    Whitehawk Therapeutics

    Endometrial Cancer

    phase 1 small molecule active

    1 trial

  12. Hemay020

    Tianjin Hemay Pharmaceutical Co., Ltd

    Neoplasms，Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  13. I-131-CLR1404

    Cellectar Biosciences

    Cancer

    phase 1 small molecule completed

    1 trial

  14. I124-NM404

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  15. ICG-Cisplatin Nanoprobe (NIR-II NanoM)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer, Adult

    phase 1 small molecule active

    1 trial

  16. IMP3-saRNA (YMN-136) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 1 mab active

    1 trial

  17. INC280 single agent

    Novartis Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  18. INO-1400

    INOVIO PHARMACEUTICALS, INC.

    Breast Cancer

    phase 1 mab completed

    1 trial

  19. INO-3106, INO-9012

    INOVIO PHARMACEUTICALS, INC.

    Aerodigestive Precancerous Lesions and Malignancies

    phase 1 mab completed

    1 trial

  20. INTERACT stomach

    Disc Medicine

    Stomach Cancer with metastasis in the peritoneum

    phase 1 other active

    1 trial

  21. IRX4204

    IO Biotech

    Lung Cancer, Nonsmall Cell

    phase 1 small molecule terminated

    1 trial

  22. Imatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor Cancer

    phase 1 small molecule active

    1 trial

  23. Infigratinib

    BridgeBio Oncology Therapeutics

    Breast Cancer

    phase 1 small molecule terminated

    1 trial

  24. Intraperitoneal infusion of FAST CEA-targeted CAR-T

    Chongqing Precision Biotech Co., Ltd

    Colorectal Cancer

    phase 1 mab active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources